Key Highlights
- ARK Invest purchased 39,691 shares of Tesla valued at $14.3M distributed across three ETFs on April 6, 2026
- Tesla shares declined more than 2% to close at $352.82 following disappointing Q1 delivery figures
- ARK divested 25,240 Teradyne shares worth $7.8M, marking the third consecutive week of selling
- Wedbush’s Dan Ives maintained his Buy recommendation with a $600 price objective for Tesla
- JPMorgan analyst Ryan Brinkman reaffirmed his Sell rating with a $145 price target
Cathie Wood’s ARK Invest executed multiple transactions on Monday, April 6, 2026, increasing its exposure to Tesla while reducing holdings in Teradyne, a semiconductor testing equipment manufacturer.
Tesla’s stock price fell over 2% during trading, settling at $352.82. The decline followed the electric vehicle maker’s announcement of underwhelming first-quarter delivery figures.
Wood accumulated 39,691 shares of Tesla distributed among three exchange-traded funds — ARK Innovation, ARK Autonomous Technology & Robotics, and ARK Space Exploration & Innovation. The combined acquisition totaled approximately $14.3 million.
This transaction represents part of a broader pattern. ARK has been consistently expanding its Tesla holdings, capitalizing on recent share price declines as strategic entry points.
Concurrently, ARK disposed of 25,240 shares of Teradyne valued at $7.8 million through its ARKK and ARKQ portfolios. This follows previous divestments on March 30 and March 31, indicating a strategic withdrawal from the semiconductor equipment company.
Analysts Remain Divided on Tesla’s Outlook
Wood’s bullish stance on Tesla isn’t universally shared among market analysts.
Wedbush’s Dan Ives, a highly regarded five-star analyst, maintained his Buy rating alongside a $600 price objective following the delivery announcement. While acknowledging the disappointing results, Ives noted that subdued demand had been largely anticipated by the analyst community.
Conversely, JPMorgan’s Ryan Brinkman maintained his Sell rating with a $145 price target, characterizing Tesla’s performance as having “collapsed” across critical operational metrics.
The substantial disparity between these price targets — $145 versus $600 — illustrates the profound disagreement among Wall Street professionals regarding Tesla’s future trajectory.
Among 32 analysts surveyed during the past three months, Tesla receives a consensus Hold rating. The breakdown consists of 13 Buy recommendations, 11 Hold ratings, and 8 Sell ratings.
The mean price target stands at $393.97, implying approximately 11.66% potential appreciation from Monday’s closing price.
Additional ARK Transactions on April 6
ARK also divested 29,773 shares of BWX Technologies for $6.4 million and 8,484 shares of Cameco for $955,043.
The investment firm additionally sold 92,758 shares of Strata Critical Medical, generating approximately $384,945. This selling activity has persisted since the previous week.
On the acquisition side, ARK purchased 4,394 shares of Kodiak AI through its ARKQ ETF, totaling $32,603. ARK has been steadily building its Kodiak AI position since March 30.
Current Market Position
As of April 6, Tesla shares ended trading at $352.82, with the consensus analyst price target of $393.97 indicating modest upside potential from present valuation levels.





